Stille

Stille EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Stille (STIL.ST) as of Oct 24, 2026 is 101.39. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 25.01 — a change of 305.40% (higher).

EV/FCF

101.39

YoY

305.40%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Stille is 2025 101.39 . EV/FCF (Enterprise Value to Free Cash Flow) of Stille was 2024 25.01 . It decreases by 305.40% higher compared to the previous year.

The Stille EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
171.68 SEK
Jan 1, 2019
86.77 SEK
Jan 1, 2020
-541.18 SEK
Jan 1, 2021
-138.85 SEK
Jan 1, 2022
67.42 SEK
Jan 1, 2023
57.37 SEK
Jan 1, 2024
25.01 SEK
Jan 1, 2025
101.39 SEK
The Stille EV/FCF history
YEAREV/FCFYoY
101.39+305.40%
25.01-56.41%
57.37-14.91%
67.42-148.56%
-138.85-74.34%
-541.18-723.71%
86.77-49.46%
171.68+91.61%
89.60+3.57%
86.51-48.31%
167.35-140.62%
-411.96—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

EV/FCF (Enterprise Value to Free Cash Flow) of Stille is 101.39 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Stille changed from 25.01 to 101.39, representing a 305.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Stille since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Stille with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Stille

All Key Metrics — Stille